Addition of GRGDTP peptide, which prevents cell attachment of fibronectin, reversed the AT 2 R inhibitory effect on SMC-vAT 2 migration. These results suggest that activated angiotensin II AT 2 R inhibits SMC migration via c-FN synthesis and associated cell binding.
INTRODUCTION
Normal or pathological vessel remodeling is generally described as a consequence of growth and/or phenotype alterations of the vascular smooth muscle cells (SMCs) (20) . Migration of medial SMCs within the vessel wall is however another essential aspect of the process of vascular remodeling (5, 55, 59) . Identification of the environmental signals susceptible to control SMC migration has been largely derived from studies in cultured SMCs. These include growth factors, such as platelet-derived growth factor or fibroblast growth factor, cytokines, components of the extracellular matrix (ECM) (1) , and also nitric oxide (8) and endothelial nitric oxide synthase (25). It is also well documented that matrix metalloproteinases (MMPs) by cleaving ECM components participate in promoting SMC migration (36, 61, 73) .
Accumulating evidence suggest that angiotensin II (Ang II) is an important mediator of systemic vascular remodeling. Ang II has been shown to promote hyperplasia and/or hypertrophy of vascular SMC in vitro as well as in vivo in the normal arterial wall (31) , and to participate in the myointimal proliferation response to vascular injury (13, 47, 50) . Ang II also stimulates migration of SMCs both in vitro (6) and during restenosis formation after vascular injury (46, 51) . Two major subtypes of Ang II receptors, designated AT 1 and AT 2, have been identified based on their affinity for selective receptor antagonists (reviewed in 15) . It is now currently admitted that the stimulatory effects of Ang II on either growth or migration of SMCs are attributable to the AT 1 subtype (18, 19, 29, 31, 34, 46, 51, 71) . Much less is known about the physiological roles of the AT 2 receptor, which is abundantly expressed in the developing vascular system (45, 60, 66) , and is reexpressed in adult SMCs in response to vascular injury (45) , arteriogenesis after myocardial infarction (70) , or hypoxia-induced lung vessel remodeling (11) . In vitro investigations of the function of AT 2 receptor have proven to be difficult, mainly because of low or lack of expression of this receptor in cultured SMCs (3, 31, 39, 46) , which contrasts with the abundant expression of the AT 1 subtype. Ectopically expressed AT 2 receptor in cultured SMCs has been shown to exert either an anti-proliferative (45) or apoptotic (72) effect, thereby counteracting the growth promoting action of the AT 1 receptor. Whether such an effect is accompanied by a modulation in the migratory properties of SMCs has not been explored in cultured SMCs.
In the present study, we have generated a vascular SMC line expressing the human AT 2 receptor by retroviral-mediated gene transfer, in order to compare the effect of the AT 2 receptor on SMC migration on either laminin (LAM) and fibronectin (FN) substrate. To further define the molecular basis of the action of the AT 2 receptor on SMC migration, we also investigated the effect of AT 2 receptor activation on SMC growth, cytoskeletal stiffness and expression of several ECM and cytoskeleton components. I-sarile was determined by counting the cell-associated radioactivity in an Auto-Gamma counter after solubilization in 0.1 M NaOH.
MATERIALS AND METHODS

Reagents
Preparation of membranes from SMC-v and SMC-vAT 2 cells and competitive binding studies were performed as previously described (38). Competition-binding curves were analyzed by non-linear least square curve fitting using the SCAFIT computer program (16) .
Equilibrium binding constants are reported as dissociation constant (Kd), and receptor concentration is expressed as pmol/mg of protein.
Cell culture and treatments
SMC-v and SMC-vAT 2 cells were routinely grown in DMEM supplemented with 10% FCS, 2 mM L-glutamine, antibiotics (50 µg/ml streptomycin and 50 U/ml penicillin), and 0.4 mg/ml of G418 at 37°C in a 5% CO2-95% air atmosphere. 
Cell migration assay
The cell migration assay was similar to those previously described by Varani and Ward (65) and Kiernan and ffrench-Constant (30) , with a few modifications (49) . Cells were resuspended at 40x10 6 After washing in PBS, the samples were incubated for 30 minutes at 25°C with avidin/peroxydase, and then for 10 minutes with AEC substrate to allow adequate chromogen development. The coverslides were mounted and observed by microscopy.
Immunoblot analysis
The cellular contents in desmin, tenascin, smooth muscle actin and fibronectin (c-Fn) were determined by Western blot analysis. Lysate proteins (4µg to 10 µ g) were resolved by electrophoresis on 7.5% SDS-acrylamide gel and electrophoretically transferred to Hybond-C nitrocellulose membranes (Amersham Corp.). The membranes were incubated for 1 hour 45
at 25°C with either mAb anti-smooth muscle actin (1:7,000) (clone 1A4, Dako), mAb anti-cFn (1:7,000) (clone FN-3 E 2, Sigma), mAb anti-tenascin C (1:3,000) (cloneBC-24, Sigma) or anti-desmin polyclonal antibody (1:4,000) (52) in TBS (pH 7.4) containing 0.1% Tween-20.
After washing, the membranes were incubated with anti-mouse IgG-or anti-rabbit IgGconjugated to horseradish peroxydase (1:5,000) (Amersham Corp.). Immunoreactive bands were visualized by enhanced chemiluminescence (Amersham) and quantified by densitometry using a computer-based imaging system (Gel Doc 1000; Biorad).
Analysis of cell fibronectin secretion activity
Cells were stimulated with Ang II as described. After 12 hours, 35 The beads were washed four times with IP buffer, and immunoprecipitates were analyzed by SDS-gel polyacrylamide on 7.5% acrylamide gels, and visualized with phosphoimager.
Measurements of DNA and protein contents
Cells were plated (40x10 3 /cm 2 ) on 6-well plates and allowed to attach in DMEM-0.2% FCS for 24 hours at 37°C. They were pre-incubated for 15 minutes with losartan, in the absence or presence of PD123319, and then treated for 24 or 48 hours as described in the previous section. The DNA total content was measured by fluorometry using the Hoechst bisbenzimide dye H33342 as described (53) . After measurement, the medium containing the H33342 dye was removed, the plates were rinsed with PBS and frozen with liquid nitrogen and stored at -80°C. Protein measurement was performed as already described.
Statistical analysis
Results are expressed as means ± SEM. The statistical significance of differences between the various cell treatments was determined by one-way analysis of variance, and group-to-group comparison was made by Scheffe's F test. The accepted level of significance was P<0.05.
RESULTS
Expression of AT 2 receptor in rat vascular SMCs
Vascular SMCs infected with the human AT 2 receptor gene display a high increase in binding activity in contrast to cells infected with empty vector (Fig. 1A) . The AT 2 receptor binds the radioligand in a saturable manner with a binding capacity of 770 fmol/mg of protein (data not shown). Binding assays were conducted in the presence of a saturating concentration of losartan to prevent binding of the radioligand to the AT 1 receptor subtype (Fig. 1B) . was further increased by 48 h but was still reduced when Ang II was added to the media (Fig.   3B ). Quantitative analysis of the drops indicated that the migration of SMC-vAT 2 cells was significantly inhibited in the presence of Ang II, by 23.1% (P < 0.001) after 24 h (Fig. 3C) and by 18.2% (P < 0.01) after 48 h (Fig. 3D) . High concentrations of CGP42112A, which per se has no effect on SMC-AT 2 migration (see Fig. 3C , 3D ), completely prevented the inhibitory effect of Ang II on cell migration (Fig. 3, all panels) , confirming that the action of Ang II is specifically mediated through the AT 2 receptor subtype. On the other hand, PD123319 not only failed to prevent the inhibitory effect of Ang II but also reduced SMCvAT 2 cell migration by 25% (P < 0.001) after 24 h, and by 39% after 48 h (P < 0.001) ( Fig.   3C and 3D ), in the absence of Ang II stimulation. Surprisingly, PD123319 similarly inhibited the migration of control SMC-v cells after 24 h and 48 h (Fig. 4) . We conclude from these results that PD123319 exerts an AT 2 -independent inhibitory action on SMC migration that masks its antagonistic effect on the migration inhibition caused by AT 2 receptor activation.
Inhibition of cell migration by the AT 2 receptor is concomitant with increased c-Fn secretion and fiber formation.
To define the molecular basis of the inhibitory action of the AT 2 receptor on SMC migration, we examined the impact of AT 2 receptor activation on both SMCv-AT 2 cell growth and expression of cytoskeletal (actin, desmin) and ECM (tenascin, c-Fn) proteins. (Fig. 5A ,5B). The c- 
AT 2 -mediated inhibition of SMC migration is due to the attachment of newly synthesized c-Fn.
To determine whether the increased binding of c-Fn is responsible for the inhibition of cell migration, we examined the effect of the GRGDTP peptide on the expression of c-Fn and the migration properties of SMC-vAT 2 cells. GRGDTP, as well a GRGETP control peptide, had no effect on either basal or Ang II-stimulated c-Fn synthesis and secretion in SMC-vAT 2 cells (Fig. 6A, 6B ). However, GRGDTP markedly reduced the Ang II-dependent increase in c-Fn staining at the cell surface (Fig. 6C versus Fig. 5C ), indicating that this peptide specifically prevents cell attachment of c-Fn.
Importantly, the GRGDTP peptide, which per se had no effect on SMC-AT 2 cell basal migration, completely prevented the inhibitory effect of Ang II on cell migration (Fig. 7, all   panels ). These results demonstrate that the AT 2 -dependent inhibition of SMC migration is directly due to c-Fn attachment to the cells.
DISCUSSION
In this study, we demonstrate that AT 2 is not enough to alter the strength of linkages between integrins and the cytosleletal apparatus (67) . However, the observation that GRGDTP peptide prevented both AT 2 -dependent cell binding of c-Fn (Fig. 6 ) and inhibition of cell migration (Fig. 7) indicates that the inhibitory action of AT 2 is due to cell attachment of c-Fn. This is in agreement with the lack of migration of SMCs on FN substrate (Fig. 2A) . These results are also consistent with the demonstration that 'superfibronectin', which resembles matrix fibers, greatly enhances cell adhesive properties and suppresses cell migration ( For each time, data were obtained from two independent experiments (N = 2) (4-7 drops per condition in each experiment) and are expressed as the mean ± SEM arbitrary units (AU). 
